321 related articles for article (PubMed ID: 25827960)
21. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
Hale ME; Dvergsten C; Gimbel J
J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naïve patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study.
Steiner DJ; Sitar S; Wen W; Sawyerr G; Munera C; Ripa SR; Landau C
J Pain Symptom Manage; 2011 Dec; 42(6):903-17. PubMed ID: 21945130
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Quality of Life, Functioning, Disability, and Work/School Productivity Following Treatment with an Extended-Release Hydrocodone Tablet Formulated with Abuse-Deterrence Technology: A 12-month Open-label Study in Patients with Chronic Pain.
Hale ME; Zimmerman TR; Ma Y; Malamut R
Pain Pract; 2017 Feb; 17(2):229-238. PubMed ID: 26857424
[TBL] [Abstract][Full Text] [Related]
24. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial.
McKenzie R; O'Fallon A; Dale J; Demitrack M; Sharma G; Deloria M; Garcia-Borreguero D; Blackwelder W; Straus SE
JAMA; 1998 Sep 23-30; 280(12):1061-6. PubMed ID: 9757853
[TBL] [Abstract][Full Text] [Related]
25. A multicenter, randomized, double-blind, placebo-controlled trial of intravenous ibuprofen 400 and 800 mg every 6 hours in the management of postoperative pain.
Southworth S; Peters J; Rock A; Pavliv L
Clin Ther; 2009 Sep; 31(9):1922-35. PubMed ID: 19843482
[TBL] [Abstract][Full Text] [Related]
26. Morphine, gabapentin, or their combination for neuropathic pain.
Gilron I; Bailey JM; Tu D; Holden RR; Weaver DF; Houlden RL
N Engl J Med; 2005 Mar; 352(13):1324-34. PubMed ID: 15800228
[TBL] [Abstract][Full Text] [Related]
27. Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study.
Rauck RL; Nalamachu S; Wild JE; Walker GS; Robinson CY; Davis CS; Farr SJ
Pain Med; 2014 Jun; 15(6):975-85. PubMed ID: 24517082
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study.
Hale ME; Ahdieh H; Ma T; Rauck R;
J Pain; 2007 Feb; 8(2):175-84. PubMed ID: 17145204
[TBL] [Abstract][Full Text] [Related]
29. Testosterone replacement therapy of opioid-induced male hypogonadism improved body composition but not pain perception: a double-blind, randomized, and placebo-controlled trial.
Glintborg D; Vaegter HB; Christensen LL; Bendix E; Graven-Nielsen T; Andersen PG; Andersen M
Eur J Endocrinol; 2020 Jun; 182(6):539-548. PubMed ID: 32213659
[TBL] [Abstract][Full Text] [Related]
30. The influence of hydrocortisone substitution on the quality of life and parameters of bone metabolism in patients with secondary hypocortisolism.
Wichers M; Springer W; Bidlingmaier F; Klingmüller D
Clin Endocrinol (Oxf); 1999 Jun; 50(6):759-65. PubMed ID: 10468948
[TBL] [Abstract][Full Text] [Related]
31. Analgesic efficacy and tolerability of intravenous morphine versus combined intravenous morphine and oxycodone in a 2-center, randomized, double-blind, pilot trial of patients with moderate to severe pain after total hip replacement.
Joppich R; Richards P; Kelen R; Stern W; Zarghooni K; Otto C; Böhmer A; Petzke F; Treptau T; Lefering R; Bäthis H; Neugebauer E
Clin Ther; 2012 Aug; 34(8):1751-60. PubMed ID: 22795613
[TBL] [Abstract][Full Text] [Related]
32. Lubiprostone for Opioid-Induced Constipation Does Not Interfere with Opioid Analgesia in Patients with Chronic Noncancer Pain.
Spierings EL; Brewer RP; Rauck RL; Losch-Beridon T; Mareya SM
Pain Pract; 2017 Mar; 17(3):312-319. PubMed ID: 26990171
[TBL] [Abstract][Full Text] [Related]
33. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study.
Johannsson G; Bergthorsdottir R; Nilsson AG; Lennernas H; Hedner T; Skrtic S
Eur J Endocrinol; 2009 Jul; 161(1):119-30. PubMed ID: 19383806
[TBL] [Abstract][Full Text] [Related]
34. Hydrocortisone Dose Influences Pain, Depressive Symptoms and Perceived Health in Adrenal Insufficiency: A Randomized Controlled Trial.
Werumeus Buning J; Brummelman P; Koerts J; Dullaart RP; van den Berg G; van der Klauw MM; Sluiter WJ; Tucha O; Wolffenbuttel BH; van Beek AP
Neuroendocrinology; 2016; 103(6):771-8. PubMed ID: 26646751
[TBL] [Abstract][Full Text] [Related]
35. The effect of electroacupuncture on opioid-like medication consumption by chronic pain patients: a pilot randomized controlled clinical trial.
Zheng Z; Guo RJ; Helme RD; Muir A; Da Costa C; Xue CC
Eur J Pain; 2008 Jul; 12(5):671-6. PubMed ID: 18035566
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
[TBL] [Abstract][Full Text] [Related]
37. Buprenorphine transdermal system and quality of life in opioid-experienced patients with chronic low back pain.
Miller K; Yarlas A; Wen W; Dain B; Lynch SY; Brennan MJ; Ripa SR
Expert Opin Pharmacother; 2013 Feb; 14(3):269-77. PubMed ID: 23374027
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial.
Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R
Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717
[TBL] [Abstract][Full Text] [Related]
39. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days.
Riff DS; Duckor S; Gottlieb I; Diamond E; Soulier S; Raymond G; Boesing SE
Clin Ther; 2009 Oct; 31(10):2072-85. PubMed ID: 19922878
[TBL] [Abstract][Full Text] [Related]
40. Opioid-induced hypogonadism: why and how to treat it.
De Maddalena C; Bellini M; Berra M; Meriggiola MC; Aloisi AM
Pain Physician; 2012 Jul; 15(3 Suppl):ES111-8. PubMed ID: 22786450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
